Una S. Ryan
Known title: DirectorCIK: 0001255349
Associated companies
Transaction History
| RNXT | ▼ Sell | Other | 26,838 | $25K | 4/22/2022 | View on chart |
| RNXT | ▼ Sell | Other | 16,206 | $26K | 4/22/2022 | View on chart |
| RNXT | ▼ Sell | Other | 6,332 | $25K | 3/3/2022 | View on chart |
| RNXT | ▼ Sell | Other | 47,789 | $200K | 3/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
RenovoRx publishes peer-reviewed case series in oncology journal
RenovoRx reported that researchers at Hackensack Meridian Health’s Jersey Shore University Medical Center published a peer-reviewed case series in Case Reports in Oncology. This update highlights clinical activity involving the company's products, adding to the scientific evidence base. The stock currently trades near its 52-week low, with an average analyst target significantly higher than the current price.
RenovoRx publishes peer-reviewed case series in oncology journal. RenovoRx reported that researchers at Hackensack Meridian Health’s Jersey Shore University Medical Center published a peer-reviewed case series in Case Reports in Oncology. This update highlights clinical activity involving the company's products, adding to the scientific evidence base. The stock currently trades near its 52-week low, with an average analyst target significantly higher than the current price.